InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the complete record of transactions filed by Stengone Carmine N., Chief Executive Officer. Insider active across 1 companies, notably Contineum Therapeutics, Inc.. In total, 2 disclosures have been recorded. The latest transaction was filed on 24 February 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Declarations2 total
US$4,7014,400 shares@ US$1.0684100.0% of flow
Class A Common Stock
SEC:0001437749-26-005892·
€4,7014,400 shares@ €1.06840.0011% mcap50.0% of flow
Class A Common Stock
SEC:0001437749-26-005892:0·
2 of 2 declarations
About Stengone Carmine N.
Carmine N. Stengone is the Chief Executive Officer of Contineum Therapeutics, Inc. He is responsible for the strategic and operational direction of the company. His expertise in the biotechnology sector is essential for the development of new therapeutic solutions.
